Infectious chest complications in haematological malignancies  by Bommart, S. et al.
Diagnostic and Interventional Imaging (2013) 94,  193—201
CONTINUING EDUCATION PROGRAM: FOCUS
Infectious  chest  complications  in  haematological
malignancies
S.  Bommarta,∗,  A.  Bourdinb,  A.  Makinsonc,
G.  Duranda,  A.  Micheaua,  V.  Monnin-Baresa,
F.  Kleina,  H.  Kovacsika
a Montpellier  University  Hospitals,  Arnaud  de  Villeneuve  Hospital,  Medical  Imaging,  371,
avenue Doyen-Gaston-Giraud,  34295  Montpellier  cedex  05,  France
b Montpellier  University  Hospitals,  Arnaud  de  Villeneuve  Hospital,  Department  of  Respiratory
Medicine, 371,  avenue  Doyen-Gaston-Giraud,  34295  Montpellier  cedex  05,  France
c Montpellier  University  Hospitals,  Gui  de  Chauliac  Hospital,  Department  of  Infectious  and
Tropical Disease,  80,  avenue  Augustin-Fliche,  34295  Montpellier  cedex  05,  France
KEYWORDS
Chest;
Haematological
disease;
Infection;
Aspergillosis;
Abstract  The  management  of  infections  in  haematology  is  dictated  by  the  patient’s  type  of
acquired  or  induced  immune  deﬁciency  (neutropenia,  deﬁciency  in  cell-mediated  or  antibody-
mediated immunity),  and  ﬁndings  from  clinical  examination,  laboratory  studies,  or  morphologic
investigations.  The  CT  scan  dominates  in  the  initial  management  and  follow-up  of  these
patients, since  clinical  features  very  often  appear  to  be  non-speciﬁc.  The  radiologist’s  role
is to  guide  the  clinician  towards  a  speciﬁc  diagnosis  such  as  aspergillosis  or  pneumocystosis,  orImmunodeﬁciency to point  them  towards  a  non-infectious  cause:  tumour  localisation,  hypervolaemia,  bronchiolitis
obliterans  suggestive  of  GVH  disease,  drug  toxicity,  or  embolism.
© 2012  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Infectious  complications  are  common  in  patients  with  haematological  malignancies.
They  develop  not  only  because  of  the  immune  deﬁciency  that  is  intrinsic  to  haemato-
logical  disease,  but  also  because  of  the  treatments  used  that  cause  immunosuppression
or  aplasia  [1].  Around  50%  of  patients  with  a  haematological  malignancy  will  present
a  pulmonary  infection  during  their  management  [2].  These  events  carry  a  heavy  bur-
den  of  morbidity  that  requires  broad-spectrum  anti-infective  chemotherapy.  They  are
the  direct  cause  of  almost  40%  of  deaths  in  this  population.  The  prognosis  corre-
lates  to  how  early  diagnosis  is  made,  meaning  that  quick  access  to  cross-sectional
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Aspergillosis and other mycoses
Many  clinical  entities  connecting  Aspergillus  and  the  lung
have  been  described,  and  these  correlate  with  the  level94  
maging  is  required:  a  key  factor  in  the  management  of
ung  disorders  is  investigating  the  possibility  of,  for  exam-
le,  a  fungal  infection  [3].  CT  scanning  has  been  shown  to
e  superior  to  standard  X-ray  imaging  for  identifying  local-
sation  and  spread  of  lesions  as  well  as  for  an  assessment
f  aetiology  [4].  CT  is  currently  recommended  with  evi-
ence  level  A  (one  or  more  good  quality  meta-analyses  or
andomised  clinical  trials)  when  there  is  a  suspicion  of  an
nfectious  chest  complication  in  a  patient  in  haematological
ncology  [5].  It  is  also  essential  for  carrying  out  or  guiding
iopsies,  whether  this  is  done  by  endoscopy  or  percutaneous
eedle  biopsy.  Microbiological  diagnosis  based  on  imaging
eatures  is  of  course  only  a  signpost  that  will  always  have
esser  sensitivity  and  speciﬁcity  than  the  Gold  Standard  of
icrobiology  testing.  Nonetheless,  the  type  and  duration  of
mmune  suppression,  when  combined  with  certain  speciﬁc
orphologic  ﬁndings,  can  point  predominantly  to  particu-
ar  pathogens  and  considering  these  factors  together  can
ssist  with  the  decision-making  process.  Lungs  are  commonly
ot  the  only  organs  involved,  and  an  associated  infectious
r  non-infectious  disease  should  always  be  searched  (see
hapter  of  non  infectious  lesions).
rientation and predisposing factors
here  are  three  main  mechanisms  causing  immunodeﬁciency
n  haematological  oncology  and  these  have  recently  been
etailed  by  Godet  et  al.  [6].  The  emergence  of  pathogens
epends  on  whether  the  patient  has  a  deﬁciency  in  the  type
f  immunity  that  is  usually  involved  in  controlling  them,  i.e.
ellular-mediated  or  antibody-mediated  immunity  [4].
Three  patterns  are  distinguished:
neutropenia,  which  is  usually  caused  by  treatment,  either
chemotherapy  or  radiotherapy.  This  encourages  bacterial
or  fungal  lung  infections  to  develop;
deﬁciencies  in  cell-mediated  immunity  (immunosuppress-
ant  treatments,  long-term  corticosteroid  use;  lympho-
proliferative  diseases,  bone  marrow  transplant).  These
encourage  infections  of  intracellular  bacteria,  mycobac-
teria,  viruses  (Herpes  virus),  fungi  (pneumocystosis),  and
parasites  (toxoplasmosis);
deﬁciencies  in  antibody-mediated  immunity  (splenec-
tomy,  hypo/ergammaglobulinemia  and  myeloma).  They
are  usually  associated  with  infections  of  Streptococcus
pneumoniae  or  Streptococcus  haemophilus.
nvestigation technique
he  chest  CT  scan  can  initially  be  carried  out  without  inject-
ng  a  contrast  media.  It  will  be  carried  out  with  contrast
nhancement  if  there  is  a  suspicion  of  pulmonary  embolism
r  if  the  abdomen  and  pelvis  are  also  to  be  examined.  Where
ronchiolitis  is  suspected,  investigations  are  completed  by
aking  expiration  cross-sections  using  low-dose  volume  CT,
r  with  four  sequential  staggered  cross-sections.  They  can
e  acquired  during  breath  hold  in  maximum  expiration  or
uring  expiration  (‘‘breathe,  breathe,  breathe’’)  [7].  To
cquire  a  good  quality  expiration  CT  the  patient  needs  to
ctively  participate,  as  does  the  technician,  so  that  the
F
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equired  functional  information  to  characterise  the  distal
irways  is  captured.
MRI  is  not  currently  indicated  in  this  context.
maging ﬁndings suggestive of infection
acterial infections
acteria  remain  the  most  common  infective  agent  caus-
ng  lung  disorders,  or  at  least  they  are  the  pathogens  that
re  most  often  identiﬁed  on  microbiology.  These  infections
hould  routinely  be  treated  with  broad-spectrum  antibiotics
argeting  staphylococci  and  Gram-negative  bacteria  [8].
acterial  infections  are  usually  non-speciﬁc,  the  radiological
ndings  being  an  opacity  or  an  uniform  alveolar  consolida-
ion  with  air  bronchogram  (Fig.  1).  This  can  be  segmental,
obar,  or  spread  across  several  lobes  [9].  The  description
f  the  imaging  features  will  attempt  to  deﬁne  the  spread
nd  the  associated  abnormalities:  underlying  parenchyma  or
leural  effusion.  Mediastinal  lymphadenopathy  can  be  found
t  the  lymph  nodes  into  which  the  infectious  process  is  drain-
ng.  More  diffuse  lymphadenopathy  may  present  when  there
s  tumour  proliferation.
In  general,  the  infection  frequently  gains  entry  via  a
entral  line  catheter  (Port  a  Cath,  PICC  line)  [10]. Often
lood  cultures  or  bacteriology  tests  using  specimens  from
he  end  of  the  catheter  are  used  to  check  for  infection  after
emoval.  In  this  speciﬁc  case,  the  purpose  of  imaging  is  to
ssess  the  spread  of  septic  localisations.  The  chest  CT  scan
s  especially  useful  for  demonstrating  relatively  cavitated
ormations  in  the  parenchyma  that  point  to  haematogenous
issemination  of  bacteria  (or  sometimes  fungus).  An  assess-
ent  of  the  heart  chambers  forms  part  of  the  assessment
f  the  spread  of  sepsis  and  this  will  look  for  thrombi  of  the
alves  pointing  to  associated  endocarditis  [11].igure 1. Forty-one-year-old male. Pneumonia revealing M1 sub-
ype acute myeloid leukaemia treated with empirical antibiotic
herapy with good progression (a, b).
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Figure 3. Forty-seven-year-old female managed for acute lym-
phoblastic leukaemia. Severe sepsis following second cycle of
induction chemotherapy. Diagnosis of invasive aspergillosis made
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of  immune  dysfunction  that  allowed  them  to  develop:
invasive  aspergillosis,  semi-invasive  aspergillosis,  chronic
necrotising  aspergillosis,  aspergillus  bronchitis,  and  ﬁnally
allergic  bronchopulmonary  aspergillosis,  which  occupies  the
extreme  end  of  this  immunological  and  clinical  spectrum.
Aggressive  opportunistic  fungal  infections  can  develop  in
patients  who  present  neutropenia  persisting  beyond  1  week
[12,13].
Invasive  pulmonary  aspergillosis  (IPA)  is  at  the  forefront
of  these  infections  and  it  entails  between  50  and  90%
mortality.  It  complicates  around  10%  of  allogeneic  bone  mar-
row  transplants  and  induction  cycles  in  acute  leukaemia.
This  diagnosis  is  considered  in  the  haematological  oncology
patients  when  they  present  severe  infection  that  remains
resistant  to  broad-spectrum  antibiotics  for  4  days  or  more.
Aspergillus  is  a  ubiquitous  fungus  and  contamination  is
airborne,  through  the  inhalation  of  spores.  When  the  cir-
cumstances  are  favourable  it  can  cause  groups  of  cases.
Aspergillus  fumigatus  is  the  most  commonly  found  pathogen
but  other  agents  can  produce  similar  pictures:  zygomyco-
sis  [14], candidiasis  (Fig.  2a  and  b).  Imaging,  and  CT  in
particular,  demonstrates  non-speciﬁc  pneumonia-like  alve-
olar  consolidation  in  fungal  infections.  One  or  more  nodular
lesions  surrounded  by  a  ‘‘ground  glass’’  halo  may  point  more
speciﬁcally  to  this  type  of  agent  (Figs.  3  and  4).  The  ground
glass  opacity  in  this  case  relates  to  the  presence  of  haemo-
rrhagic  areas  peripheral  to  the  central  infarction.  The  halo
sign  is  highly  suspicious  in  this  context,  even  though  it  has
been  demonstrated  that  this  sign  can  also  be  seen  in  other
infections  (viruses,  mycobacteria),  inﬂammatory  patholo-
gies  (Wegener’s  granulomatosis),  and  tumours  (metastases,
lepidic  growth  pattern  adenocarcinoma,  Kaposi’s  sarcoma)
[15].  A  reversed  halo  sign  is,  however,  thought  to  be  more
suggestive  of  zygomycosis.  The  progression  of  CT  features  is
marked  by  central  necrosis  and  then  retraction  which  then
gives  way  to  the  air  crescent  sign  (Fig.  5),  and  this  usually
coincides  clinically  with  recovery  from  neutropenia  [16]. As
a  general  rule,  the  presence  of  well-delineated  consolida-
tion  together  with  either  a  peripheral  halo,  an  air  crescent,
or  cavitation  are  the  signs  that  point  to  probable  IPA  based
P
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Figure 2. a,b: 56-year old female with respiratory decompensation wit
with central necrosis due to Candida tropicalis.fter transthoracic needle biopsy. Indication for right upper lobec-
omy upheld when patient recovers from aplasia taking vascular
onnections into account.
n  the  current  medical  algorithms  for  the  management  of
ebrile  patients  with  neutropenia  [17].
Apart  from  guiding  diagnosis,  the  role  of  the  radiologist  is
o  describe  the  relationships  between  these  formations  and
he  major  vessels.  This  is  because  surgery  may  be  indicated
f  localisations  are  found  close  to  vascular  structures,  in  view
f  the  risk  of  massive  haemoptysis.
Aspergillosis  can  readily  affect  the  tracheobronchial
ree,  which  translates  into  a thickening  of  the  walls,  debris
lling  the  bronchi,  or  non-speciﬁc  centrilobular  opacities.
his  presentation  occurs  more  easily  in  less  severe  forms  of
mmunodeﬁciency  [18].neumocystosis
neumocystis  jiroverci  infection  (formerly  Pneumocys-
is  carinii) is  also  a  fungal  infection  due  to  recent
hin a relapse of M4 subtype acute myeloid leukaemia. Lung disease
196  S.  Bommart  et  al.
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Figure 6. Repeat episode of fever two years after initial diag-
nosis. Ground glass opacities predominantly in the upper zones.
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Figure 4. Invasive aspergillosis, multiple nodule form.
eclassiﬁcation.  A  pneumocystosis  infection  in  a  patient  liv-
ng  with  HIV  allows  diagnosis  of  AIDS.  It  is  however  not
peciﬁc  to  this  kind  of  acquired  immune  deﬁciency  and  it
an  been  seen  irrespective  of  the  cause  of  immune  sup-
ression,  with  a  predilection  for  post-allogeneic  transplant
atients  [19]. Imaging  in  pneumocystosis  is  highly  distinct
rom  that  seen  in  other  fungal  infections.  Indeed,  the  ﬁnding
f  extensive  ‘‘ground  glass’’  opacities  predominating  in  the
pper  zones  is  highly  suggestive  of  pneumocystosis  in  this
etting  (Fig.  6).  Other  features  classically  associated  with
IV  (cystic  lesions,  crazy-paving  sign)  are  less  often  found
n  haematological  disease.  These  signs  can  be  present  when
iagnosis  has  been  delayed  due  to  a  subacute  disease  course
20].iral lung disease
iral  lung  diseases  caused  by  Herpes,  cytomegalovirus  or
aricella-zoster  virus  (VZV)  are  usually  conditions  that  are
(
a
n
igure 5. Air crescent sign during a progressing invasive aspergillosis.neumocystosis (same patient as ﬁgure 1).
eactivated  due  to  immune  deﬁciency.  Lung  infections  are
resented  as  ‘‘ground  glass’’  or  reticular  opacities  (Fig.  7)
21,22].  Alveolar  consolidation  or  nodules  are  possible  [22].
he  development  of  a  cough  during  an  epidemic  combined
ith  ﬁndings  of  bronchial  origin  or  ground  glass  opacities  on
T  points  to  a  community-acquired  virus.
uberculosis and atypical mycobacteria
hen  cell-mediated  immunity  is  affected,  this  can  cause  a
eactivation  of  tuberculosis  that  may  be  isolated  or  asso-
iated  with  other  pathogens.  Signs  of  this  diagnosis  are
onsolidation  in  the  upper  zones  with  nodular  opacities
ssociated  with  endobronchial  spread  (Fig.  8).  Disseminated
milliary)  forms  occur  most  commonly  when  the  patient  has severe  immune  deﬁciency.  In  these  cases,  multiple  regular
odules  distributed  haematogenically  may  be  observed.
Infectious  chest  complications  in  haematological  malignancies  
Figure 7. Lung disease with hypoxaemia in a 56-year old female
being monitored for lymphoma. Predominantly diffuse pattern
ground glass opacities: CMV lung infection.
Figure 8. B-lymphoma treated with CHOP in a 43-year old male.
Alveolar consolidation has developed that is related to a site of
hypermetabolism seen in the parenchyma on PET: atypical mycobac-
teria.
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Figure 9. a,b: persistent alveolar consolidation with air bronchogram 197
on-infectious lesions of the parenchyma
he  non-infectious  causes  of  parenchymal  or  vascular
nvolvement  can  be  presented  on  top  of  the  signs  of  infec-
ion.  A  routine  search  should  be  made  for  them  so  that  a
isease  that  can  be  cured  using  methods  other  than  antibi-
tics  is  not  misdiagnosed.
ulmonary oedema
 prescription  of  pre-treatment  hyperhydration  or  the  use
f  cardiotoxic  chemotherapy  such  as  anthracyclines  can  be
he  cause  of  pulmonary  oedema.  It  is  rarely  difﬁcult  to
iagnose  clinically,  although  symptoms  during  the  inter-
titial  oedema  stage  of  decompensated  left  heart  failure
an  be  more  non-speciﬁc.  If  thickening  of  the  perilobular
epta  is  present,  and  all  the  more  so  if  this  is  combined
ith  pleural  effusion,  and  even  quite  commonly  mediasti-
al  lymphadenopathy,  this  diagnosis  must  be  considered,
specially  when  it  accompanies  tangible  signs  of  lung
isease.
arenchymal tumour localisations
ymphomas  can  be  present  in  the  form  of  single  or  mul-
iple  areas  of  parenchymal  consolidation  and  images  may
e  misunderstood  to  be  suggestive  of  an  infectious  cause.
his  ﬁnding  is  very  typical  in  MALT  lymphomas  (Fig.  9a  and
).
peciﬁc  case  of  pulmonary  inﬁltration  by  leukemic
last cells
he  ﬁnding  of  diffuse  ground  glass  opacities  together
ith  acute  dyspnoea  can  be  explained  by  a  build-up
f  circulating  blast  cells  in  the  arterioles  (pulmonary
eukostasis),  usually  seen  in  acute  myeloid  leukaemia.
his  phenomenon  is  generally  accompanied  by  multiple
rgan  presentations  and  patients  often  make  poor  progress.
linical  signs  and  laboratory  studies  back  up  this  diagno-
is.
in a 79-year old male: non-Hodgkins lymphoma, MALT subtype.
1 S.  Bommart  et  al.
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Figure 10. Ground glass opacities, intralobular and perilobular
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stem  cell  transplant  recipients  will  present  respiratory  signs
of  rejection  (Graft  Versus  Host  Disease  [GVHD]).  Bronchi-
olitis  obliterans  is  one  way  in  which  it  may  be  identiﬁed.98  
Inﬁltration  of  leukemic  cells  develops  in  the  same  set-
ing  but  it  can  be  distinguished  because  in  this  case  tumour
ells  localise  to  the  interstitium,  which  explains  why  some
resentations  mimic  pulmonary  oedema  or  appear  to  be  lym-
hangitis  [23,24].
rug or radiation-induced lung disease
he  presence  of  ground  glass  opacities  with  straight  edges
n  the  irradiated  ﬁeld  that  do  not  respect  the  pleural  ﬁs-
ures,  appearing  during  radiotherapy  or  in  the  following  six
onths,  is  suggestive  of  acute  radiation-induced  lung  dis-
ase.
Furthermore,  there  are  many  treatments  used  in  haema-
ological  oncology  that  can  cause  an  immune  response
eading  to  hypersensitivity  reaction  lung  disease.  The  pre-
entation  can  be  extremely  variable  but  shows  involvement
f  the  interstitium.  The  most  classically  seen  forms  are
rouped  together  by  drug  on  the  website  Pneumotox
http://www.pneumotox.com).
The  purpose  of  multidisciplinary  consultation  is  to
xclude  other  diagnoses,  to  conﬁrm  the  chronology  of  the
atient’s  treatments  in  order  to  establish  which  one  the
esponse  may  be  attributed  to  using  extrinsic  information,
nd  possibly  to  suggest  other  investigations  for  diagnosis.
lveolar haemorrhage
cquired  or  induced  thrombocytopenia  can  predispose
atients  to  alveolar  haemorrhage.  The  ﬁlling  of  the  alve-
lar  space  appears  on  imaging  as  ground  glass  opacities,
ometimes  combined  with  a  reticular  pattern  (crazy-paving)
25]. The  patient  does  not  always  expectorate  blood  (around
5%  of  cases)  but  when  this  clinical  sign  is  present,  it  is
nother  argument  in  favour  of  this  diagnosis.  If  there  is
ny  doubt,  ﬁberoptic  bronchoalveolar  lavage  can  conﬁrm
iagnosis.  Alveolar  haemorrhage  can  also  complicate  numer-
us  other  clinical  settings  (paraneoplastic  syndrome,  drug
reatments,  viral  lung  diseases  etc.),  principally  pulmonary
edema,  which  is  discussed  above.
ulmonary alveolar proteinosis
ulmonary  alveolar  proteinosis  or  alveolar  lipoproteinosis
an  be  idiopathic  or  secondary  to  a  haematological  malig-
ancy.  It  characteristically  affects  the  interstitium,  showing
round  glass  opacities  combined  with  infralobular  and  per-
lobular  reticular  patterning  (crazy-paving)  (Fig.  10).  The
iagnosis  is  conﬁrmed  if  milky  ﬂuid  is  collected  on  bron-
hoalveolar  lavage  [26,27].
ulmonary embolism
ith  risk  factors  such  as  hyperviscosity  syndrome,  conﬁne-
ent  to  bed,  and  a  malignant  tumour  occurring  together,
hromboembolic  diseases  become  a  common  event  in  the
anagement  of  haematological  malignancies  [28]. If  a
atient  presents  dyspnoea  that  has  developed  recently
hen  the  possibility  of  this  diagnosis  should  be  investi-
ated.
F
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oeticular pattern together forming the crazy-paving sign: secondary
ulmonary alveolar proteinosis.
ronchiolitis
ronchiolitis  obliterans  with  organising  pneumonia  (BOOP,
 name  which  has  been  replaced  by  cryptogenic  organiz-
ng  pneumonia  or  COP  in  idiopathic  cases)  is  a  differential
iagnosis  identiﬁed  by  pathological  and  anatomical  ﬁndings
f  subpleural  alveolar  consolidation  that  sometimes  punc-
uates  the  course  of  a haematological  malignancy  (Fig.  11).
he  aetiopathogenesis  remains  complex  given  that  there
re  a  multitude  of  factors  that  are  potentially  implicated
drug  and  physical  treatments,  underlying  haematological
isease,  autoimmune  response  etc.).
Furthermore,  10  to  15%  of  allogeneic  haematopoieticigure 11. Fifty-eight-year-old female monitored for chronic
ymphocytic leukaemia for 13 years. Invasive aspergillosis diagnosed
nd treated 3 years ago. Signs of recurrence in the alveoli. Trans-
ronchial biopsy conﬁrmed bronchiolitis obliterans, which resolved
n corticosteroid therapy.
Infectious  chest  complications  in  haematological  malignancies  199
being
C
CFigure 12. a—d: air trapping in a 34-year old male with dyspnoea 
bronchiolitis obliterans due to GVHD.
This  presents  as  dyspnoea  and  signs  of  obstructive  dis-
ease  on  PFT.  CT  demonstrates  mosaic  lung  attenuation
that  is  more  pronounced  on  images  taken  on  expiration
(Fig.  12)  [29—31]. These  presentations  are  very  often  asso-
ciated  with  a  series  of  non-respiratory  symptoms  linked
to  the  rejection,  mainly  erythroderma  and  gastrointestinal
disorders.
h
c
m
t monitored for acute myeloid leukaemia and allogeneic transplant:
onclusion
hest  infections  are  a  common  and  serious  complication  in
aematological  oncology.  The  interpretation  of  CT  ﬁndings,
onsidered  together  with  the  setting,  assists  in  therapeutic
anagement  by  pointing  towards  a  microbiological  cause  or
o  an  intercurrent  non-infectious  pathology  (Fig.  13).
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Rigure 13. CT signs and the diagnoses they point to.
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